217 related articles for article (PubMed ID: 26948284)
1. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
Shara M; Stohs SJ; Mukattash TL
Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
[TBL] [Abstract][Full Text] [Related]
2. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
Shara M; Stohs SJ; Smadi MM
Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
[TBL] [Abstract][Full Text] [Related]
3. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
Kaats GR; Miller H; Preuss HG; Stohs SJ
Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
[TBL] [Abstract][Full Text] [Related]
4. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
[TBL] [Abstract][Full Text] [Related]
5. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
[TBL] [Abstract][Full Text] [Related]
6. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
Stohs SJ
Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
[TBL] [Abstract][Full Text] [Related]
7. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
8. Acute cardiovascular effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine in human subjects: A placebo-controlled, double-blind study.
Ratamess NA; Bush JA; Stohs SJ; Ellis NL; Vought IT; O'Grady EA; Kuper JD; Hasan SB; Kang J; Faigenbaum AD
Phytother Res; 2018 Jan; 32(1):94-102. PubMed ID: 29047215
[TBL] [Abstract][Full Text] [Related]
9. A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects.
Stohs SJ; Preuss HG; Shara M
Oxid Med Cell Longev; 2011; 2011():482973. PubMed ID: 21904645
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure and heart rate effects following a single dose of bitter orange.
Bui LT; Nguyen DT; Ambrose PJ
Ann Pharmacother; 2006 Jan; 40(1):53-7. PubMed ID: 16317106
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of ephedra-free weight-loss supplements in humans.
Haller CA; Benowitz NL; Jacob P
Am J Med; 2005 Sep; 118(9):998-1003. PubMed ID: 16164886
[TBL] [Abstract][Full Text] [Related]
12. Physiological effects following administration of Citrus aurantium for 28 days in rats.
Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
[TBL] [Abstract][Full Text] [Related]
13. Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes.
Stohs SJ; Preuss HG; Keith SC; Keith PL; Miller H; Kaats GR
Int J Med Sci; 2011 Apr; 8(4):295-301. PubMed ID: 21537493
[TBL] [Abstract][Full Text] [Related]
14. Acute hematological and mood perception effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine: A placebo-controlled, double-blind study.
Bush JA; Ratamess NA; Stohs SJ; Ellis NL; Vought IT; O'Grady EA; Kuper JD; Kang J; Faigenbaum AD
Phytother Res; 2018 Aug; 32(8):1593-1607. PubMed ID: 29672965
[TBL] [Abstract][Full Text] [Related]
15. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults.
Penzak SR; Jann MW; Cold JA; Hon YY; Desai HD; Gurley BJ
J Clin Pharmacol; 2001 Oct; 41(10):1059-63. PubMed ID: 11583473
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular toxicity of Citrus aurantium in exercised rats.
Hansen DK; George NI; White GE; Abdel-Rahman A; Pellicore LS; Fabricant D
Cardiovasc Toxicol; 2013 Sep; 13(3):208-19. PubMed ID: 23397375
[TBL] [Abstract][Full Text] [Related]
17. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
Perova IB; Eller KI; Musatov AV; Tymolskaya EV
Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
[TBL] [Abstract][Full Text] [Related]
18. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.
Min B; Cios D; Kluger J; White CM
Pharmacotherapy; 2005 Dec; 25(12):1719-24. PubMed ID: 16305290
[TBL] [Abstract][Full Text] [Related]
19.
Gutiérrez-Hellín J; Baltazar-Martins G; Rodríguez I; Lara B; Ruiz-Moreno C; Aguilar-Navarro M; Del Coso J
Eur J Sport Sci; 2021 Sep; 21(9):1273-1282. PubMed ID: 32859142
[TBL] [Abstract][Full Text] [Related]
20. Dose-Response Effects of p-Synephrine on Fat Oxidation Rate During Exercise of Increasing Intensity.
Gutiérrez-Hellín J; Del Coso J
Phytother Res; 2018 Feb; 32(2):370-374. PubMed ID: 29024325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
